Effective vaccines must overcome escape mechanisms exploited by tumor cells (e.g., antigen loss, expression of immunosuppressive cytokines, induction of Tregs and MDSC) as well as the tumor's capacity to affect T cell trafficking and normal immune regulation (e.g., via CTLA-4 and PD-1). Here, CTLA4 is linked to neoplasm.